(Q40457478)

English

Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.

scientific article published on February 2005

Statements

Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. (English)
Elsebe G Overbeek-Klumpers
William A Hallett
M Brawner Floyd
Bernard D Johnson
Ronald S Michalak
Ramaswamy Nilakantan
Carolyn Discafani
Jonathan Golas
Sridhar K Rabindran
Janis Upeslacis

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit